Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cerus Corp
(NQ:
CERS
)
6.160
USD
-0.190 (-2.99%)
Streaming Delayed Price
Updated: 1:37 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Cerus Corp
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Factors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes, Halyard Health, Deckers Outdoor, and Cerus — New Research Emphasizes Economic Growth
November 22, 2017
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of REV Group, Inc....
From
GlobeNewswire News Releases
Cerus Corporation Receives IDE Approval to Initiate Phase III ReCePI Study
November 07, 2017
Cerus Corporation (NASDAQ: CERS) today announced it has received an investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate ReCePI (A Randomized,...
From
Business Wire News Releases
Technical Insights on Biotech Stocks -- Cara Therapeutics, Catabasis Pharma, Cerus, and Genocea Biosciences
November 05, 2017
If you want a Stock Review on CARA, CATB, CERS, or GNCA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Friday, benchmark US indices were in...
From
PR Newswire
Cerus Corporation Reports Third Quarter 2017 Results
November 02, 2017
Cerus Corporation (NASDAQ:CERS) today announced financial results for the third quarter ended September 30, 2017.
From
Business Wire News Releases
Cerus to Present at Two Upcoming Conferences
October 31, 2017
Cerus Corporation (NASDAQ:CERS) announced today that management will present at two upcoming investor conferences:
From
Business Wire News Releases
Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy
October 31, 2017
Cerus Corporation (NASDAQ:CERS) announced today that it has entered into an agreement with Kedrion Biopharma to distribute the full complement of INTERCEPT Blood System products in Italy. Kedrion...
From
Business Wire News Releases
Cerus Announces Agreement with Transfusion Center of the Community of Madrid
October 30, 2017
Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a supply agreement with Centro de Transfusión de la Comunidad de Madrid (CTCM) for the INTERCEPT Blood System for platelets.
From
Business Wire News Releases
Cerus Announces National German Reimbursement for Pathogen Inactivated Platelets
October 23, 2017
Cerus Corporation (NASDAQ:CERS) announced today that the Institute for the Hospital Remuneration System (Institut für das Entgeltsystem im Krankenhaus, or InEK) in Germany will include...
From
Business Wire News Releases
Cerus to Release Third Quarter 2017 Results on November 2, 2017
October 19, 2017
Cerus Corporation (NASDAQ:CERS) announced today that its third quarter results will be released on Thursday, November 2, 2017, after the close of the stock market. The company will host a conference...
From
Business Wire News Releases
Cerus Announces First Biologics License Application Approval for U.S. Blood Center Customer
October 05, 2017
Cerus Corporation (NASDAQ:CERS) announced today that Rhode Island Blood Center received approval by the U.S. Food and Drug Administration (FDA) on their Biologics License Application (BLA) requesting...
From
Business Wire News Releases
Cerus Announces Schedule of Presentations at the 2017 AABB Annual Meeting
October 02, 2017
Cerus Corporation (NASDAQ:CERS) announced today its schedule of key events at the AABB (formerly known as the American Association of Blood Banks) Annual Meeting to be held October 7-10 in San Diego,...
From
Business Wire News Releases
Cerus to Present at Cantor Fitzgerald’s Annual Healthcare Conference on September 27, 2017
September 20, 2017
Cerus Corporation (NASDAQ:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the Cantor Fitzgerald Healthcare...
From
Business Wire News Releases
Cerus to Present at Two Upcoming Conferences
August 30, 2017
Cerus Corporation (NASDAQ:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, will present at two upcoming conferences:
From
Business Wire News Releases
Today's Research Report Coverage on Biotech Stocks -- Bellicum Pharma, Cara Therapeutics, Cerus, and Coherus Biosciences
August 28, 2017
From
PR Newswire
Cerus Corporation Reports Second Quarter 2017 Results
August 03, 2017
Cerus Corporation (NASDAQ: CERS) today announced financial results for the second quarter ended June 30, 2017.
From
Business Wire News Releases
Cerus Enters Into $40 Million Amended Growth Capital Agreement
August 02, 2017
Cerus Corporation (NASDAQ:CERS) announced today that it has entered into a $40 million amended growth capital credit facility with Oxford Finance LLC, a specialty finance firm that provides senior debt...
From
Business Wire News Releases
Cerus Announces Expanded Supply Agreement with French National Blood Service
August 01, 2017
Cerus Corporation (NASDAQ: CERS) announced today the signing of two, new, expanded contracts with Établissement Français du Sang (EFS), the French National Blood Service, for the INTERCEPT Blood...
From
Business Wire News Releases
Cerus Announces Collaboration with Central California Blood Center to Manufacture Pathogen-Reduced Cryoprecipitate
July 27, 2017
Cerus Corporation (NASDAQ:CERS) announced today an agreement with the Central California Blood Center (CCBC) in which CCBC will manufacture pathogen-reduced cryoprecipitate (“cryo”) for the company....
From
Business Wire News Releases
Cerus to Release Second Quarter 2017 Results on August 3, 2017
July 21, 2017
Cerus Corporation (NASDAQ:CERS) announced today that its second quarter results will be released on Thursday, August 3, 2017, after the close of the stock market. The company will host a conference...
From
Business Wire News Releases
INTERCEPT Blood System Highlighted at the International Society of Blood Transfusion (ISBT)
June 21, 2017
Cerus Corporation (NASDAQ:CERS) announced results of 16 abstracts presenting experiences with the INTERCEPT Blood System for platelets, plasma, and red blood cells during the 27th Regional Congress of...
From
Business Wire News Releases
Cerus Provides Update on U.S. Platelet Additive Solution (PAS) Supply
June 07, 2017
Cerus Corporation (NASDAQ:CERS) announced today that the expected Fresenius Kabi platelet additive solution (PAS) shortage the company announced on May 23, 2017, could be less disruptive to blood...
From
Business Wire News Releases
Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Cara Therapeutics, Cerus, and Concert Pharma
June 02, 2017
From
PR Newswire
Cerus Provides U.S. Business Update
May 23, 2017
Cerus Corporation (NASDAQ: CERS) announced today that it received notification last week of a pending U.S. supply shortage of a platelet additive solution (PAS) manufactured and sold by Fresenius...
From
Business Wire News Releases
First Patient Transfused in Cerus’ Phase III RedeS Study Evaluating Safety and Efficacy of the INTERCEPT Red Blood Cell System
May 15, 2017
Cerus Corporation (NASDAQ: CERS) announced today that the first patient has been transfused in Puerto Rico for the “INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika...
From
Business Wire News Releases
Cerus Announces Exercise of Additional BARDA Contract Options Totaling $46.6 million to Support INTERCEPT Red Blood Cell System Development
May 09, 2017
Cerus Corporation (NASDAQ: CERS) announced today that additional options totaling $46.6 million have been exercised under its contract with the Biomedical Advanced Research and Development Authority...
From
Business Wire News Releases
Cerus Corporation Reports First Quarter 2017 Results
May 03, 2017
Cerus Corporation (NASDAQ: CERS) today announced financial results for the first quarter ended March 31, 2017.
From
Business Wire News Releases
Cerus to Release First Quarter 2017 Results on May 3, 2017
April 19, 2017
Cerus Corporation (NASDAQ:CERS) announced today that its first quarter results will be released on Wednesday, May 3, 2017, after the close of the stock market. The company will host a conference call...
From
Business Wire News Releases
Cerus Corporation (Nasdaq: CERS) to Ring the Nasdaq Stock Market Closing Bell Remotely from the Nasdaq Entrepreneurial Center in San Francisco
April 07, 2017
From
GlobeNewswire News Releases
Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 06, 2017
Cerus Corporation (NASDAQ:CERS) announced today that, on April 3, 2017, the compensation committee of the company's board of directors granted 21 new non-executive employees options to purchase an...
From
Business Wire News Releases
Research Reports Initiation on Biotech Stocks -- Alcobra, Cerus, 22nd Century, and Moleculin Biotech
April 03, 2017
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.